About

Aims and scope

BMJ Open Diabetes Research & Care is an open access journal committed to publishing high-quality, basic and clinical research articles regarding type 1 and type 2 diabetes, and associated complications. Only original research and systematic reviews are accepted. Submissions are subject to rigorous external peer review to ensure the publication of high-quality information.

The online-only format allows for continuous updates and serves as an invaluable resource to the multidisciplinary community of endocrinology, public health/prevention and internal medicine. A rapid review process will also ensure that timely, up-to-date research is available internationally.

BMJ Open Diabetes Research & Care is published by BMJ in partnership with the American Diabetes Association.

Editorial Board

For information about BMJ Open Diabetes Research & Care Editor in Chief Dr Guillermo Umpierrez and his editorial team, please refer to the Editorial Board page

Journal information

Publication Model Open access
Frequency Continuous publication
Launch date 2014
Digital Archive LOCKSS
Indexed by Web of Science Core Collection: Science Citation Index Expanded, Emerging Sources Citation Index; MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Media), DOAJ, Google Scholar
Impact Factor N/A
Peer Review Model Single blind; the names of reviewers are hidden from the author
ISSN 2052-4897

Journal Statistics

Frequency Continuous publication
Acceptance Rate 51%
Time to Submission to First Decision 30 days
Time to Acceptance to Publication 15 days

Advertising


Online advertising – USA and Canada only

Ron Gordon
National Accounts Manager, American Medical Communications
(973) 214-4374
rgordon@americanmedicalcomm.com

Online advertising – All countries except USA and Canada

Affiliations

Founded in 1940, the American Diabetes Association funds research to prevent, cure and manage diabetes, and among its many activities delivers services to hundreds of communicates and advocates on behalf of those affected by the disease. www.diabetes.org

Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.

The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ has been a member since 2009.

All BMJ Open Diabetes Research & Care articles are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) licence. These licenses let others distribute, remix, tweak and build upon your work. See our open access page for more details.

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results.